Pharma R&D Today

Is a new Alzheimer’s disease drug in the offing?

Posted on September 23rd, 2016 by Patrick C. May, PH.D. in Pharma R&D

A high profile paper describing a prospective new therapy for Alzheimer’s disease (AD) was being shared around the internet recently. The paper, “The antibody aducanumab reduces Ab plaques in Alzheimer’s disease,” authored by Sevigny et al., was published on-line in Nature (Sevigny et al., 2016) and describes the preclinical and early clinical development of aducanumab, (more…)